These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9722696)

  • 1. Etiopathogenesis of cardiovascular disease: hemostasis, thrombosis, and vascular medicine.
    Lowe GD
    Ann Periodontol; 1998 Jul; 3(1):121-6. PubMed ID: 9722696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic and rheological variables and risk of cardiovascular disease.
    Lowe GD; Rumley A; Whincup PH; Danesh J
    Semin Vasc Med; 2002 Nov; 2(4):429-39. PubMed ID: 16222632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study.
    Lowe G; Rumley A; Norrie J; Ford I; Shepherd J; Cobbe S; Macfarlane P; Packard C
    Thromb Haemost; 2000 Oct; 84(4):553-8. PubMed ID: 11057849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Circulation; 2007 Apr; 115(16):2119-27. PubMed ID: 17404162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh Artery Study.
    Lee AJ; Mowbray PI; Lowe GD; Rumley A; Fowkes FG; Allan PL
    Circulation; 1998 Apr; 97(15):1467-73. PubMed ID: 9576427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease.
    Woodward M; Rumley A; Tunstall-Pedoe H; Lowe GD
    Br J Haematol; 1999 Feb; 104(2):246-57. PubMed ID: 10050704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle and hemostatic risk factors for ischemic heart disease : the Caerphilly Study.
    Yarnell JW; Sweetnam PM; Rumley A; Lowe GD
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):271-9. PubMed ID: 10634829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood fluidity, fibrinogen, and cardiovascular risk factors of occlusive arterial disease: results of the Aachen study.
    Koscielny J; Jung EM; Mrowietz C; Kiesewetter H; Latza R
    Clin Hemorheol Microcirc; 2004; 31(3):185-95. PubMed ID: 15322324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives--a preliminary report.
    Scarabin PY; Vissac AM; Kirzin JM; Bourgeat P; Amiral J; Agher R; Guize L
    Thromb Haemost; 1999 Sep; 82(3):1112-6. PubMed ID: 10494773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.
    Lip PL; Blann AD; Jones AF; Lip GY
    Eye (Lond); 1998; 12 ( Pt 2)():245-51. PubMed ID: 9683948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The possible role of hemorheology in atherothrombogenesis.
    Koenig W; Ernst E
    Atherosclerosis; 1992 Jun; 94(2-3):93-107. PubMed ID: 1632876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemostatic and rheological factors in intermittent claudication: the influence of smoking and extent of arterial disease.
    Lee AJ; Fowkes FG; Rattray A; Rumley A; Lowe GD
    Br J Haematol; 1996 Jan; 92(1):226-30. PubMed ID: 8562400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of inflammatory and hemostatic variables with the risk of recurrent stroke.
    Woodward M; Lowe GD; Campbell DJ; Colman S; Rumley A; Chalmers J; Neal BC; Patel A; Jenkins AJ; Kemp BE; MacMahon SW
    Stroke; 2005 Oct; 36(10):2143-7. PubMed ID: 16151030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease.
    Wannamethee SG; Lowe GD; Shaper AG; Rumley A; Lennon L; Whincup PH
    Eur Heart J; 2005 Sep; 26(17):1765-73. PubMed ID: 15817606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study.
    Lowe GD; Lee AJ; Rumley A; Price JF; Fowkes FG
    Br J Haematol; 1997 Jan; 96(1):168-73. PubMed ID: 9012704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen and cardiovascular risk.
    Heinrich J; Assmann G
    J Cardiovasc Risk; 1995 Jun; 2(3):197-205. PubMed ID: 7584794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Eur Heart J; 2007 Feb; 28(3):354-62. PubMed ID: 17213229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of cardiovascular risk factors on hemorheologic parameters in cerebrovascular patients].
    Szapáry L; Szóts M; Horváth B; Márton Z; Alexy T; Késmárky G; Juricskay I; Nagy F; Gaál V; Pálfi A; Koltai K; Tóth K
    Orv Hetil; 2003 Jun; 144(22):1085-90. PubMed ID: 12847818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease.
    Pearson TA; LaCava J; Weil HF
    Am J Clin Nutr; 1997 May; 65(5 Suppl):1674S-1682S. PubMed ID: 9129509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical activity and hemostatic and inflammatory variables in elderly men.
    Wannamethee SG; Lowe GD; Whincup PH; Rumley A; Walker M; Lennon L
    Circulation; 2002 Apr; 105(15):1785-90. PubMed ID: 11956120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.